What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Antibody
His primary areas of study are Immunology, Virology, Vaccination, Antibody and CD8.
As part of his studies on Immunology, Xiao-Song He often connects relevant areas like Microarray.
His studies in Vaccination integrate themes in fields like Genetics and Immunization.
His study in Antibody is interdisciplinary in nature, drawing from both Infectious disease and Genome.
The concepts of his CD8 study are interwoven with issues in Epitope, Cytotoxic T cell, Innate immune system and Molecular biology.
Cytokine is closely connected to T cell in his research, which is encompassed under the umbrella topic of Cytotoxic T cell.
His most cited work include:
- Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection (592 citations)
- Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers (404 citations)
- Lineage Structure of the Human Antibody Repertoire in Response to Influenza Vaccination (266 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Immunology, Virology, Cytotoxic T cell, Antibody and Vaccination.
Immune system, Primary biliary cirrhosis, T cell, Autoimmunity and Antigen are the core of his Immunology study.
His Immune system study combines topics in areas such as Interferon and Confidence interval.
His Cytotoxic T cell research includes elements of Epitope, Molecular biology and CD8.
Xiao-Song He has researched Vaccination in several fields, including Influenza A virus, Immunization and Antibody Repertoire.
His studies in Influenza vaccine integrate themes in fields like Hemagglutinin and Immunoglobulin gene.
He most often published in these fields:
- Immunology (89.29%)
- Virology (50.89%)
- Cytotoxic T cell (25.00%)
What were the highlights of his more recent work (between 2012-2020)?
- Immunology (89.29%)
- Antibody (29.46%)
- Vaccination (30.36%)
In recent papers he was focusing on the following fields of study:
Xiao-Song He mainly focuses on Immunology, Antibody, Vaccination, Virology and Primary biliary cirrhosis.
His works in Immune system, Autoimmunity, Chemokine, Cytokine and T cell are all subjects of inquiry into Immunology.
His Antibody study combines topics from a wide range of disciplines, such as Nod, Escherichia coli infection and Antigen.
His work carried out in the field of Vaccination brings together such families of science as Hemagglutination assay, Influenza A virus and Antibody Repertoire.
His Virology research is multidisciplinary, incorporating elements of Lineage and Immunization.
The concepts of his Primary biliary cirrhosis study are interwoven with issues in Cytotoxic T cell, Transforming growth factor, Case-control study, Liver cancer and Interleukin.
Between 2012 and 2020, his most popular works were:
- Lineage Structure of the Human Antibody Repertoire in Response to Influenza Vaccination (266 citations)
- Lineage Structure of the Human Antibody Repertoire in Response to Influenza Vaccination (266 citations)
- Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis. (78 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Antibody
His main research concerns Antibody, Vaccination, Immunology, Autoantibody and Primary biliary cirrhosis.
Antibody is a subfield of Genetics that Xiao-Song He investigates.
His study in Vaccination is interdisciplinary in nature, drawing from both Infectious disease, Isotype, Genome, Immunoglobulin M and Antibody Repertoire.
His CD40 research extends to Immunology, which is thematically connected.
The Autoantibody study combines topics in areas such as Germinal center, B cell, High endothelial venules, Antigen and Naive B cell.
His studies deal with areas such as Cytokine, Receptor, Cell damage, Immunopathology and Major histocompatibility complex as well as Primary biliary cirrhosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
